Victoza and Ribavirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Victoza (liraglutide) and Ribavirin (ribavirin). Common drug interactions include nausea among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Victoza and Ribavirin. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 42,880 Victoza users. Check the latest studies of Victoza.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.



On Jul, 21, 2026

27 people who take Victoza and Ribavirin together, and have interactions are studied.

Victoza and Ribavirin drug interactions.

What are the common drug interactions of Victoza and Ribavirin, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Anaemia (lack of blood)
  4. Fatigue (feeling of tiredness)
  5. Rash
  6. Vomiting
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Asthenia (weakness)
  9. Dyspepsia (indigestion)
  10. Fungal infection

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Headache (pain in head)
  4. Insomnia (sleeplessness)
  5. Decreased appetite
  6. Pruritus (severe itching of the skin)
  7. Rash macular (small, flat red spots)
  8. Back pain
  9. Dyspepsia (indigestion)
  10. Flushing (the warm, red condition of human skin)

What are the common drug interactions of Victoza and Ribavirin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Angioedema (rapid swelling of the dermis)
  2. Blood pressure decreased
  3. Constipation
  4. Diabetes mellitus inadequate control
  5. Fatigue (feeling of tiredness)
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Asthenia (weakness)
  5. Blood glucose increased
  6. Diarrhoea
  7. Headache (pain in head)
  8. Fatigue (feeling of tiredness)
  9. Liver disorder (liver diseases)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Anaemia (lack of blood)
  3. Abdominal pain upper
  4. Blood glucose increased
  5. Decreased appetite
  6. Device failure
  7. Erythema (redness of the skin)
  8. Insomnia (sleeplessness)
  9. Nocturia (the need to get up in the night to urinate)
  10. Peripheral swelling

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 9 people, 33.33%
  2. High Blood Pressure: 7 people, 25.93%
  3. Lipids Abnormal: 3 people, 11.11%
  4. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 2 people, 7.41%
  5. Muscle Spasms (muscle contraction): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Victoza and Ribavirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Victoza and Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Victoza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Victoza and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on liraglutide and ribavirin (the active ingredients of Victoza and Ribavirin, respectively), and Victoza and Ribavirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: